Cumberland Pharmaceuticals (CPIX) Non-Current Assets (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Non-Current Assets data on file, last reported at $38.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets changed 0.39% year-over-year to $38.2 million; the trailing twelve-month figure through Mar 2026 stood at $150.6 million (down 6.81% YoY), and the FY2025 full-year result was $39.8 million, up 1.62% from the prior year.
• Non-Current Assets eased to $38.2 million in Q1 2026, from $39.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $51.4 million in Q1 2022 to a low of $36.0 million in Q3 2025.
• A 5-year average of $42.9 million and a median of $42.9 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets grew 21.36% in 2022 and decreased 15.99% in 2025, its largest moves.
• Tracing CPIX's Non-Current Assets over 5 years: stood at $47.1 million in 2022, then decreased by 2.11% to $46.1 million in 2023, then retreated by 15.05% to $39.1 million in 2024, then climbed by 1.62% to $39.8 million in 2025, then dropped by 3.92% to $38.2 million in 2026.
• Business Quant data shows CPIX's Non-Current Assets at $38.2 million in Q1 2026, $39.8 million in Q4 2025, and $36.0 million in Q3 2025.